<scp>ASP</scp>8273 tolerability and antitumor activity in tyrosine kinase inhibitor‐naïve Japanese patients with <i><scp>EGFR</scp></i> mutation‐positive non‐small‐cell lung cancer

Koichi Azuma, Kazuhiko Nakagawa, Hidetoshi Hayashi et al.|Cancer Science|2018

Cited by 35